Showing results (81-90 of 209) with videos related to

Sort By:
Pageof 21
American Heart Journal|September 7, 2016
Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trialMichael D Ezekowitz, Charles V Pollack, Paul Sanders, et al.
Circulation|May 9, 2007
Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Ronald S Freudenberger, Anne S Hellkamp, Jonathan L Halperin, et al.
Pharmacogenomics|December 23, 2011
Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALUStuart A Scott, Manishkumar Patel, Suparna Martis, et al.
Clinical Cardiology|March 17, 2018
Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry programWilliam F McIntyre, David Conen, Brian Olshansky, et al.
American Heart Journal|November 2, 2013
Risk factors associated with the incidence and progression of mitral annulus calcification: the multi-ethnic study of atherosclerosisSammy Elmariah, Matthew J Budoff, Joseph A C Delaney, et al.
Vascular Medicine (London, England)|June 1, 2014
Controversies regarding the new oral anticoagulants for stroke prevention in patients with atrial fibrillationBibhu D Mohanty, Patrick M Looser, Lakshmi R Gokanapudy, et al.
The American Journal of Cardiology|January 26, 2021
Relation of Antecedent Symptoms to the Likelihood of Detecting Subclinical Atrial Fibrillation With Inserted Cardiac MonitorsJames A Reiffel, Atul Verma, Peter R Kowey, et al.
Chest|July 24, 2008
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Daniel E Singer, Gregory W Albers, James E Dalen, et al.
The American Journal of Cardiology|September 26, 2016
Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT)Gregory Y H Lip, Albert L Waldo, John Ip, et al.
American Journal of Cardiovascular Disease|November 23, 2020
Cardiovascular risk and complications associated with COVID-19Chayakrit Krittanawong, Anirudh Kumar, Joshua Hahn, et al.
Pageof 21